No Picture
Business

Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in 1000 patients […]

Glenmark introduces 3-in-1 inhaler therapy for COPD, promising reduction in risk of severe attacks and improvement in lung function
Business

Glenmark introduces 3-in-1 inhaler therapy for COPD promising reductionin risk of severe attacks and improvement in lung function

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of a Single Inhaler Triple Therapy AIRZ-FF – a combination of two bronchodilators, Glycopyrronium & Formoterol and the inhalation corticosteroid Fluticasone […]